1. An integrated RF-receive/B0-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T
- Author
-
Ovidiu C. Andronesi, Lawrence L. Wald, Elfar Adalsteinsson, Daniel P. Cahill, Jacob K. White, Jorg Dietrich, Bijaya Thapa, Morteza Esmaeili, Andre van der Kouwe, Nicolas S Arango, Jason P. Stockmann, Tracy T. Batchelor, Zhe Wang, and Bernhard Strasser
- Subjects
Materials science ,Metabolite ,Brain tumor ,lcsh:Medicine ,Imaging techniques ,Article ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,chemistry.chemical_compound ,Laser linewidth ,0302 clinical medicine ,Nuclear magnetic resonance ,Glioma ,medicine ,lcsh:Science ,Multidisciplinary ,lcsh:R ,Magnetic resonance spectroscopic imaging ,Shim (magnetism) ,Neurochemistry ,Human brain ,medicine.disease ,Cancer metabolism ,medicine.anatomical_structure ,chemistry ,Array coil ,Cancer imaging ,lcsh:Q ,Biomedical engineering ,030217 neurology & neurosurgery - Abstract
Metabolic imaging of the human brain by in-vivo magnetic resonance spectroscopic imaging (MRSI) can non-invasively probe neurochemistry in healthy and disease conditions. MRSI at ultra-high field (≥ 7 T) provides increased sensitivity for fast high-resolution metabolic imaging, but comes with technical challenges due to non-uniform B0 field. Here, we show that an integrated RF-receive/B0-shim (AC/DC) array coil can be used to mitigate 7 T B0 inhomogeneity, which improves spectral quality and metabolite quantification over a whole-brain slab. Our results from simulations, phantoms, healthy and brain tumor human subjects indicate improvements of global B0 homogeneity by 55%, narrower spectral linewidth by 29%, higher signal-to-noise ratio by 31%, more precise metabolite quantification by 22%, and an increase by 21% of the brain volume that can be reliably analyzed. AC/DC shimming provide the highest correlation (R2 = 0.98, P = 0.001) with ground-truth values for metabolite concentration. Clinical translation of AC/DC and MRSI is demonstrated in a patient with mutant-IDH1 glioma where it enables imaging of D-2-hydroxyglutarate oncometabolite with a 2.8-fold increase in contrast-to-noise ratio at higher resolution and more brain coverage compared to previous 7 T studies. Hence, AC/DC technology may help ultra-high field MRSI become more feasible to take advantage of higher signal/contrast-to-noise in clinical applications.
- Published
- 2020